Rapidfilm ®: An innovative pharmaceutical form designed to improve patient compliance

The aim of the research was to assess the bioequivalence between Rapidfilm ®, a new patented delivery system, versus the traditional orodispersible tablet (ODT). A randomized, two-way, single dose, crossover, bioequivalence study was conducted in 24 fasting, healthy volunteers with two formulations...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of pharmaceutics 2010-06, Vol.393 (1), p.55-60
Hauptverfasser:	Reiner, Valentina, Giarratana, Nadia, Monti, Nunzia Ceppi, Breitenbach, Armin, Klaffenbach, Peter
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Analysis of Variance Antiemetics - administration & dosage Antiemetics - adverse effects Antiemetics - blood Antiemetics - chemistry Antiemetics - pharmacokinetics Bioequivalence Biological and medical sciences Chemistry, Pharmaceutical Chromatography, Liquid Cross-Over Studies Delivery system Dosage Forms Drug Carriers Drug Compounding Female General pharmacology Humans Male Medical sciences Ondansetron Ondansetron - administration & dosage Ondansetron - adverse effects Ondansetron - blood Ondansetron - chemistry Ondansetron - pharmacokinetics Orally disintegrating tablet (ODT) Orodispersible film Orodispersible tablet Patient Compliance Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Serotonin Antagonists - administration & dosage Serotonin Antagonists - adverse effects Serotonin Antagonists - blood Serotonin Antagonists - chemistry Serotonin Antagonists - pharmacokinetics Tandem Mass Spectrometry Therapeutic Equivalency
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!